Atossa Therapeutics, Inc. ( ATOS) - Key Metrics
ATOS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.95 | -$1.08 | -$1.08 |
| 2026Q1 | $0 | -$1.11 | -$1.11 | -$1.11 |
| 2025Q4 | $0 | -$1.27 | -$1.22 | -$1.22 |
| 2025Q3 | $0 | -$1.01 | -$0.70 | -$0.70 |
| 2025Q2 | $0 | -$0.98 | -$0.84 | -$0.84 |
ATOS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.51 |
| 2026Q1 | 0% | -1.18 |
| 2025Q4 | 0% | -1.74 |
| 2025Q3 | 0% | -3.22 |
| 2025Q2 | 0% | -3.18 |
ATOS
Price: $2.59
52 week price:
Earnings Per Share: -4.34 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 530800
Ebitda: -2.0 millionMarket Capitalization: 25.9 million